(MedPage Today) -- WASHINGTON - At 5 years, more patients maintained better HIV suppression with raltegravir (Isentress) than with efavirenz (Sustiva) when each was combined with standard treatment, researchers reported here.
via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment